Mammalian target of rapamycin complex 1 is involved in differentiation of regenerating myofibers in vivo

Muscle and Nerve

Volumn 42, Issue 5, 2010, Pages 778-787

  Miyabara, Elen H ^a   Conte, Talita C ^a   Silva, Meiricris T ^a   Baptista, Igor L ^a   Bueno Jr , Carlos ^a   Fiamoncini, Jarlei ^a   Lambertucci, Rafael H ^a   Serra, Carmen S ^a   Brum, Patricia C ^a   Pithon Curi, Tania ^a   Curi, Rui ^a   Aoki, Marcelo S ^a   Oliveira, Antonio C ^a   Moriscot, Anselmo S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Neonatal MHC; Protein synthesis; Regeneration; Skeletal muscle; Tetanic contraction

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYOSIN HEAVY CHAIN; RAPAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL DIFFERENTIATION; CELL SIZE; CONTROLLED STUDY; MALE; MUSCLE CELL; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE; SKELETAL MUSCLE SATELLITE CELL; SOLEUS MUSCLE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL PROLIFERATION; FREEZING; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MYOSIN HEAVY CHAINS; ORGAN SIZE; PHOSPHORYLATION; RATS; RATS, WISTAR; REGENERATION; RIBOSOMAL PROTEIN S6 KINASES; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 78149336658     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21754     Document Type: Article

References (45)

1. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001;91:534-551. (Pubitemid 32681081)
2. Charge SB, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 2004;84:209-238.
3. Vandenburgh HH, Karlisch P, Shansky J, Feldstein R. Insulin and IGF-I induce pronounced hypertrophy of skeletal myofibers in tissue culture. Am J Physiol 1991;260:C475-C484.
4. Adams GR, Haddad F, Baldwin KM. Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol 1999;87:1705-1712.
5. Chakravarthy MV, Davis BS, Booth FW. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 2000;89:1365-1379.
6. Rabinovsky ED, Gelir E, Gelir S, Lui H, Kattash M, DeMayo FJ, et al. Targeted expression of IGF-1 transgene to skeletal muscle accelerates muscle and motor neuron regeneration. FASEB J 2003;17:53-55.
7. Musaro A, McCullagh KJ, Naya FJ, Olson EN, Rosenthal N. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 1999;400:581-585.
8. +-dependent calcineurin signalling pathway. Nature 1999;400:576-581.
9. Irintchev A, Zweyer M, Cooper RN, Butler-Browne GS, Wernig A. Contractile properties, structure and fiber phenotype of intact and regenerating slow-twitch muscles of mice treated with cyclosporin A. Cell Tissue Res 2002;308:143-156. (Pubitemid 34493970)
10. Sakuma K, Nishikawa J, Nakao R, Watanabe K, Totsuka T, Nakano H, et al. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathol (Berl) 2003;105:271-280.
11. Miyabara EH, Aoki MS, Soares AG, Moriscot AS. Expression of tropism- related genes in regenerating skeletal muscle of rats treated with cyclosporin-A. Cell Tissue Res 2005;319:479-489.
12. Miyabara EH, Aoki MS, Moriscot AS. Cyclosporin A preferentially attenuates skeletal slow-twitch muscle regeneration. Braz J Med Biol Res 2005;38:559-563.
13. Serrano AL, Murgia M, Pallafacchina G, Calabria E, Coniglio P, Lomo T, et al. Calcineurin controls nerve activity-dependent specifi- cation of slow skeletal muscle fibers but not muscle growth. Proc Natl Acad Sci USA 2001;98:13108-13113.
14. Dupont-Versteegden EE, Knox M, Gurley CM, Houle JD, Peterson CA. Maintenance of muscle mass is not dependent on the calcineurin- NFAT pathway. Am J Physiol 2002;282:C1387-C1395.
15. Schmelzle T, Hall MN. TOR, a central controller of cell growth. Cell 2000;103:253-262.
16. Ge Y, Wu AL, Warnes C, Liu J, Zhang C, Kawasome H, et al. mTOR regulates skeletal muscle regeneration in vivo through kinase-dependent and kinase-independent mechanisms. Am J Physiol 2009;297:C1434-C1444.
17. Alessi DR, Downes CP. The role of PI 3-kinase in insulin action. Biochim Biophys Acta 1998;1436:151-164.
18. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biol 2001;3:1014-1019.
19. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biol 2001;3:1009-1013.
20. Latres E, Amini AR, Amini AA, Griffiths J, Martin FJ, Wei Y, et al. Insulin- like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem 2005;280:2737-2744.
21. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A, et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biol 2004;6:1122-1128. (Pubitemid 39468014)
22. Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument- Bromage H, et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004;14:1296-1302.
23. Gao XM, Wong G, Wang B, Kiriazis H, Moore XL, Su YD, et al. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis. J Hypertens 2006;24:1663-1670.
24. Morini CC, Pereira EC, Selistre de Araujo HS, Ownby CL, Salvini TF. Injury and recovery of fast and slow skeletal muscle fibers affected by ACL myotoxin isolated from Agkistrodon contortrix laticinctus (broadbanded copperhead) venom. Toxicon 1998;36:1007-1024.
25. Bancroft JD. Enzyme histochemistry. New York: Churchill Livingstone; 1996. p 391-410.
26. Carpenter S, Karpati G. Pathology of skeletal muscle. New York: Churchill Livingstone; 1984.
27. Stirewalt WS, Low RB. Effects of insulin in vitro on protein turnover in rat epitrochlearis muscle. Biochem J 1983;210:323-330.
28. Duguez S, Bihan MC, Gouttefangeas D, Feasson L, Freyssenet D. Myogenic and nonmyogenic cells differentially express proteinases, Hsc/Hsp70, and BAG-1 during skeletal muscle regeneration. Am J Physiol Endocrinol Metab 2003;285:E206-E215.
29. McLoon LK, Wirtschafter J. Activated satellite cells in extraocular muscles of normal adult monkeys and humans. Invest Ophthalmol Vis Sci 2003;44:1927-1932.
30. Karpati G, Carpenter S, Prescott S. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 1988;11:795-803.
31. Davis CE, Harris JB, Nicholson LV. Myosin isoform transitions and physiological properties of regenerated and re-innervated soleus muscles of the rat. Neuromuscul Disord 1991;1:411-421.
32. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci 2002;99:9213-9218.
33. Wernig A, Irintchev A, Lange G. Functional effects of myoblast implantation into histoincompatible mice with or without immunosuppression. J Physiol 1995;484:493-504.
34. Wernig A, Irintchev A. "Bystander" damage of host muscle caused by implantation of MHC-compatible myogenic cells. J Neurol Sci 1995;130:190-196.
35. Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, et al. Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nature Cell Biol 2005;7:286-294.
36. Terada N, Patel HR, Takase K, Kohno K, Nairn AC, Gelfand EW. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci USA 1994;91:11477-11481.
37. Palmer RM, Thompson MG, Knott RM, Campbell GP, Thom A, Morrison KS. Insulin and insulin-like growth factor-I responsiveness and signalling mechanisms in C2C12 satellite cells: effect of differentiation and fusion. Biochim Biophys Acta 1997;1355:167-176.
38. Anthony JC, Yoshizawa F, Anthony TG, Vary TC, Jefferson LS, Kimball SR. Leucine stimulates translation initiation in skeletal muscle of postabsorptive rats via a rapamycin-sensitive pathway. J Nutr 2000;130:2413-2419.
39. Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Devel 2006;20:1692-1708.
40. Miyabara EH, Martin JL, Griffin TM, Moriscot AS, Mestril R. Overexpression of inducible 70-kDa heat shock protein in mouse attenuates skeletal muscle damage induced by cryolesioning. Am J Physiol 2006;290:C1128-C1138.
41. Feasson L, Stockholm D, Freyssenet D, Richard I, Duguez S, Beckmann JS, et al. Molecular adaptations of neuromuscular disease-associated proteins in response to eccentric exercise in human skeletal muscle. J Physiol 2002;543:297-306. (Pubitemid 34947315)
42. Stupka N, Tarnopolsky MA, Yardley NJ, Phillips SM. Cellular adaptation to repeated eccentric exercise-induced muscle damage. J Appl Physiol 2001;91:1669-1678.
43. Gerdes J, Lemke H, Baisch H,Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715.
44. Jerkovic R, Argentini C, Serrano-Sanchez A, Cordonnier C, Schiaffino S. Early myosin switching induced by nerve activity in regenerating slow skeletal muscle. Cell Struct Funct 1997;22:147-153.
45. Park IH, Chen J. Mammalian target of rapamycin (mTOR) signaling is required for a late-stage fusion process during skeletal myotube maturation. J Biol Chem 2005;280:32009-32017.